Clinical Trials Logo

Clinical Trial Summary

A Clinical Study Comparatively Evaluating the Pharmacokinetics, Pharmacodynamics and Safety of Intravenous Administration of HSK3486 Injectable Emulsion in Patients with Chronic Renal Impairment and Subjects with Normal Renal Functions


Clinical Trial Description

This is a single-center, open-label, non-randomized, parallel-controlled Phase I clinical study carried out in subjects with varying degrees (mild or moderate) of renal impairment, and age-, weight-, and gender-matched subjects with normal renal functions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04142970
Study type Interventional
Source Haisco Pharmaceutical Group Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date January 5, 2020
Completion date August 18, 2020

See also
  Status Clinical Trial Phase
Terminated NCT00782639 - Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients Phase 4